Ignite Creation Date:
2024-05-06 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06206681
Status:
RECRUITING
Last Update Posted:
2024-03-07
First Post:
2024-01-04
Brief Title:
Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
Sponsor:
Sun Yat-sen University
Organization:
Sun Yat-sen University
Study Overview
Official Title:
Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to assess the long-term efficacy and safety of ultrapulse carbon dioxide CO₂ laser excision in the treatment of eyelid tumors including xanthelasma pigmented nevi keratoses and so on
Detailed Description:
-Background The assessment of the efficacy and safety of Ultrapulse CO₂ laser in treating eyelid lesions is crucial for clinical applications This study aims to evaluate the effectiveness of super-pulsed CO₂ laser in treating different types of eyelid lesions particularly marginal and large lesions to provide comprehensive clinical guidance and decision support
-Main Objectives A retrospective analysis of the efficacy and safety of Ultrapulse CO₂ laser treatment for various types of eyelid lesions including xanthelasma pigmented nevi keratoses and so on
-Study Design This study will include 1000 patients diagnosed with eyelid lesions including xanthelasma pigmented nevi keratoses and so on All patients undergoing Ultrapulse CO₂ laser treatment The evaluation will focus on the efficacy and safety of Ultrapulse CO₂ laser treatment for different types of eyelid lesions
-Study Population and Anticipated Enrollment Patients with eyelid lesions n1000
-Inclusion Criteria Clinically diagnosed with eyelid lesions including xanthelasma pigmented nevi keratoses and so on
No history of photosensitivity bleeding or coagulation disorders Willing to attend follow-up appointments as scheduled
-Exclusion Criteria Presence of infection in the target area Allergy to lidocaine Keloid-prone or poor skin repair ability Pregnant or lactating Recent history of severe infectious diseases active skin diseases or major diseases affecting the cardiovascular liver kidney endocrine and hematopoietic systems History of malignant tumors or immune system disorders
-Main Objectives A retrospective analysis of the efficacy and safety of Ultrapulse CO₂ laser treatment for various types of eyelid lesions including xanthelasma pigmented nevi keratoses and so on
-Study Design This study will include 1000 patients diagnosed with eyelid lesions including xanthelasma pigmented nevi keratoses and so on All patients undergoing Ultrapulse CO₂ laser treatment The evaluation will focus on the efficacy and safety of Ultrapulse CO₂ laser treatment for different types of eyelid lesions
-Study Population and Anticipated Enrollment Patients with eyelid lesions n1000
-Inclusion Criteria Clinically diagnosed with eyelid lesions including xanthelasma pigmented nevi keratoses and so on
No history of photosensitivity bleeding or coagulation disorders Willing to attend follow-up appointments as scheduled
-Exclusion Criteria Presence of infection in the target area Allergy to lidocaine Keloid-prone or poor skin repair ability Pregnant or lactating Recent history of severe infectious diseases active skin diseases or major diseases affecting the cardiovascular liver kidney endocrine and hematopoietic systems History of malignant tumors or immune system disorders
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None